PL353054A1 - Fluorene derivatives as integrin inhibitors - Google Patents

Fluorene derivatives as integrin inhibitors

Info

Publication number
PL353054A1
PL353054A1 PL00353054A PL35305400A PL353054A1 PL 353054 A1 PL353054 A1 PL 353054A1 PL 00353054 A PL00353054 A PL 00353054A PL 35305400 A PL35305400 A PL 35305400A PL 353054 A1 PL353054 A1 PL 353054A1
Authority
PL
Poland
Prior art keywords
fluorene derivatives
integrin inhibitors
integrin
inhibitors
fluorene
Prior art date
Application number
PL00353054A
Other languages
English (en)
Polish (pl)
Inventor
Wolfgang Stahle
Simon Goodman
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL353054A1 publication Critical patent/PL353054A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL00353054A 1999-08-07 2000-07-26 Fluorene derivatives as integrin inhibitors PL353054A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19937394A DE19937394A1 (de) 1999-08-07 1999-08-07 Fluorenderivate
PCT/EP2000/007153 WO2001010841A2 (fr) 1999-08-07 2000-07-26 Derives de fluorene

Publications (1)

Publication Number Publication Date
PL353054A1 true PL353054A1 (en) 2003-10-06

Family

ID=7917613

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353054A PL353054A1 (en) 1999-08-07 2000-07-26 Fluorene derivatives as integrin inhibitors

Country Status (18)

Country Link
EP (1) EP1208088A2 (fr)
JP (1) JP2003506439A (fr)
KR (1) KR20020012631A (fr)
CN (1) CN1368962A (fr)
AR (1) AR025042A1 (fr)
AU (1) AU6828600A (fr)
BR (1) BR0013083A (fr)
CA (1) CA2380981A1 (fr)
CZ (1) CZ2002298A3 (fr)
DE (1) DE19937394A1 (fr)
HK (1) HK1049006A1 (fr)
HU (1) HUP0202464A3 (fr)
MX (1) MXPA02001297A (fr)
NO (1) NO20020592L (fr)
PL (1) PL353054A1 (fr)
SK (1) SK1402002A3 (fr)
WO (1) WO2001010841A2 (fr)
ZA (1) ZA200201873B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101102808B1 (ko) * 2010-04-13 2012-01-05 윤태삼 라이저 인장 장치
US8574899B2 (en) 2010-12-22 2013-11-05 Vladimir B Serikov Methods for augmentation collection of placental hematopoietic stem cells and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0478660A4 (en) * 1989-06-22 1992-05-20 Nova Pharmaceutical Corporation Pharmaceutical compositions and methods for treating inflammation
RU95104898A (ru) * 1994-03-31 1996-12-27 Бристоль-Мейерз Сквибб Компани (US) Имидазолсодержащие ингибиторы фарнезид-протеинтрансферазы, способ лечения связанных с ней заболеваний
JP2000506538A (ja) * 1996-03-29 2000-05-30 ジー．ディー．サール アンド カンパニー メタ―置換フェニレン誘導体
DE19654483A1 (de) * 1996-06-28 1998-01-02 Merck Patent Gmbh Phenylalanin-Derivate
CA2214931A1 (fr) * 1996-09-26 1998-03-26 Henry Uhlman Bryant Tetrahydrobenzo-a-fluorenes et methode d'utilisation

Also Published As

Publication number Publication date
CZ2002298A3 (cs) 2002-04-17
MXPA02001297A (es) 2004-07-16
ZA200201873B (en) 2003-08-27
WO2001010841A2 (fr) 2001-02-15
AU6828600A (en) 2001-03-05
HK1049006A1 (zh) 2003-04-25
KR20020012631A (ko) 2002-02-16
CA2380981A1 (fr) 2001-02-15
SK1402002A3 (en) 2002-06-04
NO20020592D0 (no) 2002-02-06
JP2003506439A (ja) 2003-02-18
WO2001010841A3 (fr) 2001-09-07
HUP0202464A3 (en) 2003-02-28
NO20020592L (no) 2002-04-04
HUP0202464A2 (hu) 2002-12-28
DE19937394A1 (de) 2001-02-08
EP1208088A2 (fr) 2002-05-29
BR0013083A (pt) 2002-04-23
CN1368962A (zh) 2002-09-11
AR025042A1 (es) 2002-11-06

Similar Documents

Publication Publication Date Title
AU5379900A (en) Thiophene integrin inhibitors
GB9900416D0 (en) Inhibitors
EG23817A (en) 4-Phenyl-pyridine derivatives
HUP0201535A2 (en) 5-cyano-2-aminopyrimidine derivatives
IL148167A0 (en) Amino-triazolopyridine derivatives
HK1040076A1 (zh) 作為整聯蛋白抑制劑的喹嗪酮
IL145739A0 (en) 13-methyl-erythromycin derivatives
GC0000338A (en) 5-Phenyl-pyrimidine derivatives
IL149584A0 (en) New phenalkyloxy-phenyl derivatives
HK1044940A1 (zh) 異噁唑咪唑羧酰胺衍生物
AU2541000A (en) Beta-phenylalanine derivatives as integrin antagonists
GC0000191A (en) 4-Phenyl-pyrimidine derivatives
AU2001276027A1 (en) Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors
HK1042695A1 (zh) 蛋白酶抑制劑
GB9925880D0 (en) B-Carboline derivatives
HK1049667A1 (zh) 整聯蛋白αVβ3的抑制劑
IL150132A0 (en) Cyclopenteneone derivatives
HK1045987A1 (zh) 3-氨基-2-苄基-1-苯基-丙烷衍生物
GC0000256A (en) Ethanesulfonyl-piperidine derivatives
AP2001002327A0 (en) 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives
AU3595900A (en) Tyrosine alkoxyguanidines as integrin inhibitors
HK1049666A1 (zh) 新型整合蛋白αVβ3抑制劑
PL353054A1 (en) Fluorene derivatives as integrin inhibitors
AU2001284247A1 (en) Bicyclic enamide derivatives being integrin inhibitors
GB9929341D0 (en) Inhibitors